Colorectal Cancer Tx Often Hampered by Epigenetics (CME/CE)
(MedPage Today) — An epigenetic change common in colorectal cancer predicts poor response to chemotherapy, researchers found.
(MedPage Today) — An epigenetic change common in colorectal cancer predicts poor response to chemotherapy, researchers found.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information: verify here.